摘要
目的:探讨中药菝葜不同提取物对卵巢癌细胞的活性影响。方法:采用溶剂法利用正丁醇和乙酸乙酯提取菝葜中的有效成分,获得菝葜不同提取部位。采用CCK-8法检测菝葜不同提取物(0,50,100,150,200μg·ml-1)对低侵袭力A2780及高侵袭力HO-8910PM卵巢癌细胞存活率的影响,同时观察不同时间点24,48,72 h两种卵巢癌细胞的状态。结果:正丁醇提取部位(SCR-B)对A2780和HO-8910PM卵巢癌细胞的IC50分别为47.5,69.2μg·ml-1,乙酸乙酯提取部位(SCR-E)对A2780和HO-8910细胞的IC50分别为147.9,166.0μg·ml-1;菝葜提取物对两种卵巢细胞A2780及HO-8910PM均有抑制作用,并呈剂量及时间依赖性。结论:SCR-B对卵巢癌细胞活性的抑制率强于SCR-E,且其对A2780细胞的抑制作用强于HO-8910人卵巢癌细胞。SCR-B对卵巢癌细胞具有更好的抑制作用。
Objective: To investigate the effects of different extracts of Smilax china L on the activity of ovarian cancer cells. Methods:Solvent extraction method was used to extract the active ingredients of Smilax china L. , and CCK-8 assay method was ap-plied to detect the influence of different Smilax china L. extracts (0, 50, 100, 150 and 200μg·ml-1 ) on the survival rate of ovarian cancer cells including low invasiveness A2780 cells and high invasiveness HO-8910PM cells. At the same time, the status of the two kinds of ovarian cancer cells at different time points (24, 48 and 72 h) was observed. Results:The IC50 of N-butanol extracts (SCR-B) on HO-8910 and A2780 ovarian cancer cells was 47. 5 μg· ml-1 and 69. 2 μg· ml-1 , respectively, and that of ethyl acetate ex-tracts (SCR-E) on A2780 and HO-8910 cells was 147. 9 μg· ml-1 and 166. 0 μg· ml-1, respectively. Smilax china L. extracts had the inhibition against both A278 and HO-8910PM ovarian cells in a dose-and time-dependent manner. Conclusion:The inhibitory activity of SCR-B against ovarian cancer cells is stronger than that of SCR-E, and SCR-B has stronger inhibition against A2780 cells than against HO-8910 cells. SCR-B has better inhibition against ovarian cancer cells.
出处
《中国药师》
CAS
2015年第3期373-375,共3页
China Pharmacist
关键词
菝葜
不同提取物
卵巢癌
Different extracts
Ovarian cancer